Drug stocks gain; Cell Therapeutics rebounds

Drug stocks gain in early action while shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin's lymphoma treatment pixantrone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.